A detailed history of Principal Securities, Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Principal Securities, Inc. holds 102 shares of BNTX stock, worth $11,534. This represents 0.0% of its overall portfolio holdings.

Number of Shares
102
Previous 150 32.0%
Holding current value
$11,534
Previous $12.1 Million 0.51%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$78.36 - $124.66 $3,761 - $5,983
-48 Reduced 32.0%
102 $12.1 Million
Q2 2024

Jul 31, 2024

SELL
$80.36 - $102.87 $321 - $411
-4 Reduced 2.6%
150 $12.1 Million
Q1 2024

May 10, 2024

BUY
$88.96 - $112.35 $2,579 - $3,258
29 Added 23.2%
154 $14.2 Million
Q4 2023

Feb 07, 2024

BUY
$90.91 - $112.75 $11,363 - $14,093
125 New
125 $13.2 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.